Cellulitis News and Research

Latest Cellulitis News and Research

Genetically predicted height linked to risk for several common health conditions

A large genetic study by the U.S. Department of Veteran Affairs' Million Veteran Program (MVP)) has found that a person's height may affect their risk for several common health conditions in adulthood.

2 Jun 2022

‘Go ahead and vote me out’: What other places can learn from Santa Rosa’s tent city

It was early May, and officials in this Northern California city known for its farm-to-table dining culture and pumped-up housing prices were frantically debating how to keep covid-19 from infiltrating the homeless camps proliferating in the region's celebrated parks and trails.

8 Apr 2021

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs).

17 Nov 2020

Medieval medicine to tackle antibiotic resistance

Biofilm-associated infections are notoriously difficult to treat, and they also play a role in antibiotic resistance as more antimicrobials are urgently needed to treat biofilm-associated infections. These biofilms act as protective layers that prevent the antibiotics from reaching and destroying the targeted bacteria.

29 Jul 2020

Medieval remedy can help treat modern day infections

Antibiotic resistance is an increasing battle for scientists to overcome, as more antimicrobials are urgently needed to treat biofilm-associated infections.

28 Jul 2020

Interleukin-12 electroporation led to clinical responses in patients with advanced melanoma

Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.

6 May 2020

New computer model predicts suicide risk

Suicide is now the second most common cause of death among American youth. Fatal suicides rose 30 percent between 2000 and 2016, and 2016 alone saw 1.3 million nonfatal suicide attempts.

25 Apr 2020

Study uncovers impact of both low and high iron counts

A global study looking at the role that iron plays in 900 diseases has uncovered the impact of both low and high iron counts – and the news is mixed.

21 Jun 2019

Medical students improve Wikipedia articles on skin-related diseases

A group of medical students recruited to improve Wikipedia articles on skin-related diseases, saw millions more views of those stories following their editing, highlighting the value of expert input on the popular web encyclopedia.

4 Apr 2019

Bruin Biometrics receives FDA approval for SEM Scanner

Bruin Biometrics, LLC has been granted U.S. Food and Drug Administration marketing authorization for the SEM Scanner, becoming the world’s first FDA-authorised device to objectively alert clinicians to specific anatomical areas of a patient’s body at increased risk for developing pressure damage.

7 Jan 2019

Notes and coins harbor life threatening bacteria, including MRSA and VRE

A new study has found that the cash and the coins that are in circulation are covered in over 19 types of bacteria that can be potentially deadly.

4 Oct 2018

Researchers discover new bacteria in Cornwall

A new species of bacteria has been discovered on a man in Cornwall.

12 Sep 2018

Study shows that clinical diagnosis is not best predictor of avoidable hospitalization

The care of long-term nursing home patients can be fragmented by hospitalizations and re-hospitalizations, which are especially burdensome for frail older adults.

29 Aug 2018

Innovation in Wound Care

There are many definitions of hard-to-heal. More conventionally, it's based on underlying etiology of the wound, but in practice it's any wound that has not healed within a timely fashion. This is often due to a lack of coordinated care.

From Neem Biotech 22 Aug 2018

NovaDigm Therapeutics initiates NDV-3A Phase 2a study for reduction of S. aureus in military trainees

NovaDigm Therapeutics, a company developing innovative immuno-therapeutics and preventative vaccines for fungal and bacterial infections, today announced the initiation of a Phase 2a study evaluating NDV-3A for the reduction of Staphylococcus aureus (S. aureus) colonization in a high-risk population of military trainees.

19 Apr 2018